These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 2691145)

  • 1. Strategies to manage the post-MI patient with ventricular arrhythmias.
    Weinberg B; Zipes D
    Clin Cardiol; 1989 Jul; 12(7 Suppl 3):III86-90. PubMed ID: 2691145
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Late potentials, myocardial kinetics and ventricular vulnerability as markers of sudden death after myocardial infarct].
    D'Aulerio M; Gronda M; Prando MD; Occhetta E; Makmur J; Rossi L; Rossi P
    G Ital Cardiol; 1986 Feb; 16(2):114-26. PubMed ID: 3721103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ventricular arrhythmias: medical therapy, device treatment, and indications for electrophysiologic study.
    Sager PT; Batsford WP
    Cardiol Clin; 1988 Feb; 6(1):37-47. PubMed ID: 3048673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of ventricular arrhythmias occurring in patients after myocardial infarction.
    Cain ME
    Angiology; 1988 Mar; 39(3 Pt 2):307-20. PubMed ID: 3281519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Rhythm disorders and infarction].
    Amann FW
    Ther Umsch; 1991 Aug; 48(8):543-8. PubMed ID: 1681595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Stratification of the arrhythmia risk after acute myocardial infarct].
    Pedretti RF
    Ital Heart J Suppl; 2000 Sep; 1(9):1123-37. PubMed ID: 11140281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk stratification for malignant arrhythmic events in patients with an acute myocardial infarction: role of an open infarct-related artery and the signal-averaged ECG.
    Hermosillo AG; Araya V; Casanova JM
    Coron Artery Dis; 1995 Dec; 6(12):973-83. PubMed ID: 8723020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current approaches to evaluation and management of patients with ventricular arrhythmias.
    Buxton AE; Kirk MM; Michaud GF
    Med Health R I; 2001 Feb; 84(2):58-62. PubMed ID: 11272662
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Arrhythmia recurrence in patients with an old myocardial infarct treated by implantable defibrillator: an analysis according to the initial clinical presentation].
    Vacca M; Mont L; Valentino M; Sambola A; Madariaga R; Matas M; Brugada J
    Rev Esp Cardiol; 1999 Dec; 52(12):1066-74. PubMed ID: 10659653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Identification of patients at risk of malignant arrhythmia in the 1st year after myocardial infarction].
    Araya-Gómez V; González-Hermosillo JA; Casanova Garcés JM; Colín L; Kershenovich S; Iturralde P
    Arch Inst Cardiol Mex; 1994; 64(2):145-59. PubMed ID: 8074586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Stratification of arrhythmia risk and therapeutic options in survivors of acute myocardial infarction].
    Arós Borau F; Loma-Osorio A; Torres Bosco A
    Rev Esp Cardiol; 1996 Mar; 49(3):157-65. PubMed ID: 8685518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. AICD treatment in 2004--state of the art.
    Budde T
    Eur J Med Res; 2006 Oct; 11(10):432-8. PubMed ID: 17107877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [How to evaluate the arrhythmogenic risk after myocardial infarction?].
    Motté G; Slama M; Sebag C; Dinanian S; Gueniche C
    Arch Mal Coeur Vaiss; 1992 Nov; 85(11 Suppl):1671-6. PubMed ID: 1304140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The clinical significance of ventricular arrhythmias after myocardial infarction.
    Pratt CM; Seals AA; Luck JC
    Cardiol Clin; 1984 Feb; 2(1):3-11. PubMed ID: 6400002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Long-term outcome of pharmacological and nonpharmacological treatment for ventricular arrhythmias].
    Ohnishi S; Kasanuki H
    J Cardiol; 2000 Mar; 35 Suppl 1():75-84. PubMed ID: 10834174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Infarct tissue heterogeneity assessed with contrast-enhanced MRI predicts spontaneous ventricular arrhythmia in patients with ischemic cardiomyopathy and implantable cardioverter-defibrillator.
    Roes SD; Borleffs CJ; van der Geest RJ; Westenberg JJ; Marsan NA; Kaandorp TA; Reiber JH; Zeppenfeld K; Lamb HJ; de Roos A; Schalij MJ; Bax JJ
    Circ Cardiovasc Imaging; 2009 May; 2(3):183-90. PubMed ID: 19808591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Role of spectral turbulence analysis of ECG in predicting risk of arrhythmia after myocardial infarction].
    Vado A; Bruna C; Rossetti G; Isoardi D; Cherasco E; Borello W; Uslenghi E
    G Ital Cardiol; 1997 Jul; 27(7):674-81. PubMed ID: 9303857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surgical decisions in the management of sudden cardiac death and malignant ventricular arrhythmias. Subendocardial resection, the automatic internal defibrillator, or both.
    Hargrove WC; Josephson ME; Marchlinski FE; Miller JM
    J Thorac Cardiovasc Surg; 1989 Jun; 97(6):923-8. PubMed ID: 2724998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Dangerous arrhythmias].
    Gertsch M; Fuhrer J
    Schweiz Med Wochenschr; 1993 May; 123(17):833-43. PubMed ID: 8497770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. QT dispersion and early arrhythmic risk during acute myocardial infarction.
    Ciolli A; Di Lorenzo M; Bevilacqua U; Lo Sardo G; Tripi M; Fidati R; Palamara A
    G Ital Cardiol; 1999 Dec; 29(12):1438-44. PubMed ID: 10687106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.